Abstract-Platinum (Pt) is the most commonly used metal for stimulating electrodes. This study aims to determine the amount of charge that can be delivered without causing irreversible electrochemical reactions (charge injection capacity, Q in j ) of Pt macroelectrodes (geometric surface area >0.001 cm 2 ) in vitro and in vivo using voltage transient measurements. Pt macroelectrodes were stimulated with biphasic charge-balanced cathodic-first constantcurrent pulses in phosphate buffered saline. Potential excursions were measured (versus Ag/AgCl electrode) and used to determine Q in j . The in vitro Q in j were compared to those measured in vivo following: acute and chronic implantation close to the retina; chronic intracochlear implantation; and acute subdural implantation, in the cat. Q in j increased with pulsewidth from 35 to 54 μC/cm 2 for respective pulse widths of 100 to 3200 μs per phase in vitro. Q in j was significantly less in vivo. There was no significant difference in Q in j between acutely (3.84 to 16.6 μC/cm 2 with pulsewidths of 100 to 3200 μs) and chronically (6.99 to 15.8 μC/cm 2 with pulsewidths of 200 to 3200 μs) implanted suprachoroidal electrodes. Intracochlear Q in j was not different to suprachoroidal Q in j , while subdural Q in j was significantly less than the suprachoroidal Q in j (p < 0.05). These results have important implications in providing guidelines on Q in j for the safe use of Pt stimulating macroelectrodes and question the relevance of measuring Q in j in vivo using voltage transients.
two mechanisms can inject charge without producing harmful electrochemical products, while the latter method can cause damage to surrounding tissues and to the stimulating electrode itself [19] . Electrolysis of water is one type of irreversible Faradaic reaction of particular concern since it can lead to localized pH changes [20] , [22] , and the evolution of gases could physically displace tissue [20] . Electrolysis of water can be avoided by ensuring that the maximum cathodic (E mc ) and anodic potentials on the electrode, during electrical stimulation stay within the "water window" [−0.6 to 0.9 V versus Ag/AgCl for Pt electrodes in phosphate buffered saline (PBS)] [23] , [24] . The amount of charge per unit area that can be delivered through an electrode without causing water electrolysis is known as the charge injection capacity (Q inj ). Dissolution of Pt is also irreversible and is a concern, as it can lead to the formation and release of toxic products [25] .
Q inj can be measured using voltage transients [23] , [26] , [27] and is a function of several variables. It is dependent on the geometry of the electrode with smaller electrodes tending to have larger Q inj [21] . Also, the charge density on nonspherical electrodes will be nonuniform with charge accumulating near the edges or other sharp points, especially during phases such as the stimulus pulse onset [28] , [29] . Q inj has been found to increase with pulsewidth when measured in vitro and is dependent on the conductivity and composition of the conducting media and temperature [21] , [30] .
A reduction of in vivo Q inj compared to in vitro Q inj has been observed in acutely and chronically implanted electrodes with materials such as iridium oxide [31] , [32] , but this has not been investigated using Pt electrodes. Biological media is different to PBS since it contains many different electrolytes and organic molecules. A decrease in ionic conductivity or obstruction to the diffusion of counter ions can lead to a decrease of Q inj in vivo [27] . Adsorption of proteins can inhibit Pt oxidation and oxide reduction [33] , [34] . The concentration of oxygen in the physiological environment is lower than in PBS, and this limits the contribution of oxygen reduction to Q inj in vivo [33] , [35] . Additionally, chronically implanted electrodes may evoke a tissue response resulting in fibrosis, further altering the electrode-tissue interface and affecting Q inj .
Several groups have estimated the electrochemical Q inj of Pt in vitro, with the consensus that 100 to 150 μC/cm 2 can be delivered with 200 μs pulses [23] , and that the maximum charge that can be delivered by exhausting all reversible charge injection mechanisms is 420 to 490 μC/cm 2 [36] for Pt macroelectrodes (defined as electrodes with geometric surface area greater than 0.001 cm 2 ). Other groups have reported Q inj in the range of 80 to 120 μC/cm 2 [37] . Fine Pt powder (Pt black) can be electroplated onto Pt electrodes to enhance the real surface area [38] and this can increase Q inj [38] , [39] . The real surface area of Pt can also be increased by laser roughening [39] , [40] which increases Q inj ; however, the surface charge density will be less uniform. Conversely, the real surface area can be decreased by polishing the electrode, resulting in a decreased Q inj [23] . In this paper, surface area always refers to the geometric surface area unless specified otherwise, and references to charge density and pulsewidth refer to the charge density or pulsewidth per phase, respectively. The real surface area of smooth Pt foil is typically 1.4 times the geometric surface area [33] , [41] . Since Q inj is dependent on a large number of variables, Q inj should be determined for each application with a method that closely mimics the conditions of the intended use. Our group has developed a retinal prosthesis which is undergoing clinical trials (NCT01603576). It uses disk-shaped Pt macroelectrodes implanted in the suprachoroidal space behind the retina [42] . As different stimulation paradigms are investigated, a broad range of stimulation parameters are likely to be used clinically. For example, perceptual responses to stimulation with long pulsewidths may be investigated since it is well known that increasing the duration of the pulsewidth decreases the current required to reach threshold [4] , [43] [44] [45] [46] [47] . A decrease in current threshold would therefore allow stimulators with lower compliance voltage to be used. In the interests of patient safety, it is vital to have boundaries on electrochemically safe stimulation parameters based on the Q inj , which can guide clinicians and psychophysics investigators.
The in vitro Q inj limits of Pt determined by various groups [23] , [33] , [36] , [40] are commonly used as safety guidelines in vivo although the effect of the differences in electrode geometry, pulsewidth, and the physiological environment on Q inj have not been fully appreciated [48] [49] [50] [51] [52] [53] [54] . Similarly, the electrodes in our retinal prosthesis design have different geometries to these prior studies, and the pulsewidths proposed for clinical use are greater than those previously investigated. Additionally, we are not aware of any studies where a systematic evaluation of Q inj for Pt electrodes in vivo has been performed. This study investigated the theoretical limits of Q inj in Pt macroelectrodes with a range of clinically relevant pulsewidths using voltage transient measurements. The Q inj of Pt was determined in vitro and in vivo in a retinal prosthesis model following both acute and chronic implantation in the suprachoroidal space of the eye. The results obtained from acute suprachoroidal implantation were additionally compared to the Q inj of subdural electrodes, while the chronic suprachoroidal results were compared to the Q inj measured in a chronically implanted intracochlear array, as both subdural and cochlea prostheses employ Pt macroelectrodes.
II. METHOD

A. Electrode Preparation
Electrode arrays were fabricated in a similar fashion to the clinical suprachoroidal retinal prostheses being developed by our group [55] , [56] . Insulated Pt-Ir wire (90%:10%) was welded to 700-μm-diameter Pt disks punched from 0.05-mmthick smooth Pt foil (purity 99.95%, Goodfellow Cambridge, U.K.). Disks were placed into a thin silicone sheet cast in-house with 700-μm-diameter perforations. 50 μm of the outer edge was covered by the silicone sheet resulting in an exposed geometric area of 2.83 × 10 −3 cm 2 with a recess of 50 μm. The Pt wires, weld joints, and one face of the Pt disks were sealed in silicone [see Fig. 1(a) ]. Prior to each stimulation experiment, electrode arrays were cleaned by ultrasonication for 10 min in detergent (Pyroneg, Diversey Australia, NSW, Australia), twice for 5 min in double distilled water, 5 min in 96% ethanol, 15 min in isopropyl alcohol, 5 min in 96% ethanol, and twice more for 5 min in double distilled water. For in vivo studies electrode arrays were also steam sterilized. Two similarly manufactured arrays with two disk electrodes each were used for a subdural implantation study.
A commercially manufactured Hybrid L14 (Cochlear Ltd., NSW, Australia) electrode array was used for intracochlear implantation [1] . The exposed geometric surface area of the intracochlear electrodes selected for this study was between 2.0 × 10 −3 and 2.3 × 10 −3 cm 2 .
B. Surgical Procedures
All animals were treated in accordance with the requirements of the Royal Victorian Eye and Ear Hospital Animal Research and Ethics Committee (Ethics Approval #10/206AB), the "Australian code of practice for the care and use of animals for scientific purposes" (2004) , and the Prevention of Cruelty to Animals Act 1986 and amendments. Suprachoroidal electrode implantation procedures were performed at the Royal Victorian Eye and Ear Hospital by vitreoretinal surgeons based on previously published methods [55] . Briefly, healthy young adult felines were anesthetized with xylazine (Troy Laboratories, Australia, 2 mg/kg) and ketamine (Troy Laboratories, Australia, 20 mg/kg) subcutaneously. Surgical anaesthesia was maintained with gaseous isofluorane (1% to 3%) in animals with chronic implants (n = 2) and intravenous sodium pentobarbital (Troy Laboratories, Australia, 10 to 30 mg/hr) for acute studies (n = 1). Intravenous sodium pentobarbital was used during stimulation. A lateral canthotomy was performed followed by a temporal peritomy. A scleral wound was created parallel and 5-mm posterior to the limbus. A suprachoroidal pocket was dissected and the electrode array inserted to a position near the area centralis. The wound was repaired by sutures. Acute suprachoroidal stimulation was performed on one animal from 1 to 72 h after implantation (n = 18 electrodes). Suprachoroidal stimulation was also performed on two other animals after a total implantation period of three months (n = 10 electrodes).
For the subdural implantation study, a craniotomy was performed over the striate cortex and a small flap in the dura was created. Two small electrode arrays, each with two disk electrodes, were inserted under the dura through the flap with the disks facing the cortex. Cortical stimulation was performed in one animal up to 2 h after implantation (n = 4 electrodes).
A separate animal was implanted with an intracochlear electrode array using the method described by Fallon et al. [57] . Stimulation was performed six months after implantation (n = 3 electrodes). Animals were overdosed with sodium pentobarbital (150 mg) at the conclusion of experiments.
C. Stimulation Protocol
One disk electrode, not used for potential transient measurements, was selected for cyclic voltammetry (CV) to verify the cleanliness of the electrode fabrication method and confirm the range of the water window. The active electrode was cycled between −0.6 and 1.2 V (versus. Ag/AgCl in 3 M KCl, CH instruments, USA) with a sweep rate of 50 mV/s (EA163, eDAQ, Australia). CV was performed in PBS (0.1 M phosphate buffer, 0.13-M NaCl, pH 7.4), and then in the suprachoroidal space following acute implantation. The water window was determined by analyzing features of the CV waveform [58] .
To determine Q inj , electrodes were stimulated with constantcurrent biphasic cathodic-first charge-balanced capacitivelycoupled (10 μF) pulses against a large Pt wire or needle counter electrode using an in-house custom-built stimulator. In addition, the stimulating and return electrodes were shorted at the end of each pulse and remained shorted until the next pulse, to ensure less than 100 nA net direct current and minimal irreversible reactions [59] . The interphase gap was 25 μs during which the electrodes were open circuit. Pulsewidths ranged from 100 to 3200 μs. The waveforms of five pulses of the stimulation current and the working electrode potential (versus. Ag/AgCl) were recorded (PXI-4072, National Instruments, USA) after the voltage transient had reached steady state.
E mc can be measured by subtracting the access voltage from the most negative potential of the voltage waveform [see Fig. 1(b) ]. However, distinguishing the access voltage from the interface polarization was found to be difficult in vivo. Thus, we used a more robust approach in which E mc was measured as the potential near the end of the interphase gap, 20 μs after the end of the cathodic phase [35] , [60] . It is important to note that the measured working electrode potential lags the actual working electrode potential, and that following the sudden voltage change at the cathodic phase offset, the measured working electrode potential exponentially approaches the actual potential. The time constant is greater in environments with significant permittivity, such as in vivo. By measuring E mc with a 20 μs delay after the cathodic phase offset, the difference in the measured and actual E mc is minimized. Measuring E mc using the potential near the end of the interphase gap or by subtracting the access voltage from the most negative potential produced similar results in vitro.
A salt bridge on the surface of the exposed skull was used to connect the Ag/AgCl reference electrode in vivo [see Fig. 1(c) ]. Moving the position of the reference electrode to different areas of the animal in vivo had minimal effect on the measured E mc . The use of Ag/AgCl reference electrodes in vivo to measure the working electrode potential has previously been described [32] , [60] . Note that the effect of distance between working microelectrodes and the reference electrode has minimal effect on measurements (personal communication).
Charge injection can cause tissue damage in several ways. Physiologically safe stimulation must operate within the water window. In the present study, Q inj is defined as the charge density that causes the working electrode potential to reach the water window limits. This is a widely accepted method of measuring Q inj in vitro [23] , [30] , [35] , [37] , [40] , [61] - [65] or in vivo [27] , [32] , [60] , [66] . In the present study, each electrode was stimulated with a current amplitude that was empirically determined for each pulsewidth such that E mc was approximately −0.6 V (the lower limit of the water window). The corresponding charge density was recorded as Q inj . The pulse rate was chosen such that the interpulse potential did not deviate by more than 100 mV from the open-circuit potential. This was 4 pulses/s in vitro, and 100 pulses/s in vivo. Electrodes were stimulated for 15 min, and waveforms were measured every 5 min in vivo to ensure that the electrode voltage waveform had reached a steady state. Because stimulus induced electrode corrosion is more apparent Fig. 2 . CVs of a Pt electrode performed in air-saturated PBS and implanted in the suprachoroidal space with a sweep rate of 50 mV/s. Hydrogen evolution did not occur at potentials more positive than −0.6 V. The sudden increase in current at potentials more positive than 0.9 V indicates oxygen evolution.
in vitro [68] , electrodes were only stimulated for 5 min, and waveforms were measured every minute in vitro. Waveforms typically stabilized within seconds of stimulation. For in vitro testing, electrodes (n = 7) were tested in PBS maintained at 37°C. Disk electrode arrays were soaked in PBS prior to in vitro stimulation and inspected to ensure that no air bubbles adhered to the electrode array surface.
The in vitro Q inj at different pulsewidths were compared with a one-way analysis of variance with the Bonferroni correction. In vitro Q inj was compared with the in vivo Q inj . Differences in chronic and acute suprachoroidal Q inj were tested with a twoway analysis of variance. Intracochlear and subdural electrodes were stimulated only using a 400-μs pulsewidth and the Q inj was compared with the suprachoroidal Q inj . Differences between suprachoroidal, intracochlear ,and subdural Q inj were tested with a one-way analysis of variance.
III. RESULTS
CV tests using our Pt electrodes showed that water electrolysis did not occur at potentials between −0.6 and 0.9 V in vivo and in vitro [see Fig. 2 ]. The in vitro CV current was more negative at potentials less than 0.15 V, presumably due to the reduction of oxygen.
Potential transients were recorded [see Fig. 3 ] and used to determine Q inj . There was negligible variation between measurements taken after 1 and 5 min of pulsing in vitro and also between measurements taken 5 and 15 min of pulsing in vivo. Q inj increased with pulsewidth and, in vitro, was 34 to 54 μC/cm 2 with 100 to 3200-μs pulsewidths (n = 7) [see Fig. 4 ]. The Q inj of 3200-μs pulses were significantly different to all other pulsewidths, 1600 μs pulses were different to all other pulsewidths except for 800 μs pulses, and 800 μs pulses were different to 100 μs pulses (one-way analysis of variance, p < 0.05).The interpulse potential (potential of the working electrode between pulses) was 89 ± 6 mV (mean ± standard error; n = 41). The maximum anodic potential did not exceed 0.9 V in any case.
The suprachoroidal Q inj in vivo was significantly less than the Q inj determined in vitro [see Figs. 3, 4] . The mean suprachoroidal Q inj in vivo was between 8.7 times less (200-μs pulsewidth) and 3.2 times less (3200-μs pulsewidth) than that measured in vitro. These factors were determined by dividing the in vitro Q inj by the mean in vivo Q inj at the respective pulsewidths. The mean suprachoroidal Q inj in the acutely implanted animals was between 3.84 to 16.6 μC/cm 2 for pulsewidths of 100 to 3200 μs (n = 18). In chronically implanted animals, suprachoroidal Q inj was between 6.99 to 15.8 μC/cm 2 for pulsewidths of 200 to 3200 μs (n = 10). There was no difference between acute and chronic suprachoroidal Q inj but there was a significant difference between all pulsewidths (two-way analysis of variance, p < 0.05).
With a pulsewidth of 400 μs, the mean (± standard error) intracochlear Q inj was 10.8 ± 0.5 μC/cm 2 (n = 3) [see Figs. 3, 4]. This was not significantly different to the Q inj of chronically implanted suprachoroidal electrodes with a 400-μs pulse. The mean (± standard error) cortical Q inj was 4.63 ± 0.04 μC/cm 2 (n = 4) with a pulsewidth of 400 μs, which is significantly less than the Q inj of acutely implanted electrodes in the suprachoroidal space (one-way analysis of variance, p = 0.002). The cortical Q inj was also significantly less than the intracochlear Q inj (p = 0.001).
IV. DISCUSSION
We have determined the electrochemical Q inj for Pt using pulsewidths between 200 and 3200 μs by measuring the charge density when Emc was at the lower limit of the water window (−0.6 V). The results demonstrated that the in vitro Q inj was up to 8.7 times greater than in vivo. As expected, in vitro Q inj was lower compared to studies using smaller electrodes [37] , [40] .
Compared to this study, Rose and Robblee reported higher Q inj in vitro with pulsewidths of 200 μs even though the electrodes were larger than those used in this study [23] . Rose and Robblee stimulated electrodes at a rate of 50 pulses/s, which is far greater than the 4 pulses/s used in the present study. Irreversible electrochemical reactions during the cathodic phase can cause the interpulse potential to become more positive. Although the interpulse potential will eventually return to the open-circuit potential, successive pulses may cause a "ratcheting" effect, leading to a more positive interpulse potential [19] . Higher pulse rates allow less time for the interpulse potential to return to a level that is closer to the open-circuit potential and this enhances the "ratcheting" effect and, thus, the value of E mc will be less negative. This may lead to an overestimation of Q inj . In this study, stimulation rates were selected to ensure that E mc measurements were not significantly affected by drifts in interpulse potential.
Q inj increased with pulsewidth and this has been shown previously for iridium oxide [26] , as well as Pt [62] electrodes. We have shown that this dependence of Q inj on pulsewidth continues at pulsewidths >400 μs. Longer pulsewidths allow more time for reactions such as hydrogen atom plating/stripping and Pt oxidation/reduction to occur which results in an increased Q inj compared to shorter pulse durations [23] . The contribution of oxygen reduction to the Q inj is also greater at longer pulsewidths [35] . The dependence of Q inj on pulsewidth was not observed by Brummer and Turner [36] . This is likely to be due to differences in the way water electrolysis was identified. Although Q inj can be increased by lengthening the pulsewidth, caution is advised since the rate of Pt dissolution also increases with pulsewidth [67] . However, Pt dissolution is inhibited by protein [68] and decreases with time in vivo [69] . Also, no studies have investigated the chronic tissue response and electrode stability following stimulation using long pulsewidths with Pt electrodes. Furthermore, the effect of pulsewidth on Q inj may vary with electrode geometry and the stimulation parameters.
The water window in vivo was found to be similar to that found in vitro and was consistent with the established literature [70] , [71] . The suprachoroidal Q inj was only 11.5% to 30.8% of Q inj in vitro. The Q inj of the cortical surface was approximately 12.7% of the Q inj in vitro with a 400-μs pulsewidth, which is a similar reduction of Q inj in activated iridium oxide electrodes implanted in the cortex [32] . A reduction in Q inj in vivo can be expected due to differences between PBS and the physiological environment, including the presence of organic species and differences in the electrolyte concentration [21] . The reduction in the in vivo Q inj was greater at short pulsewidths compared to long pulsewidths. The diffusion of counter ions in vivo may be restricted by the presence of tissues [27] . This could reduce Q inj in vivo, particularly at short pulsewidths when higher current densities are used.
The similarities in the chronic and acute suprachoroidal Q inj concurs with previous reports that chronic implantation does not damage Pt electrodes [72] . Furthermore, the results suggest that differences in the acute and chronic tissue response did not have a major impact on Q inj . A significant amount of fibrosis is unlikely to have occurred during the acute stimulation period of 1 to 72 h although a chronically implanted electrode array is expected to be encapsulated in fibrotic tissue. However, recent work has shown that the fibrosis around electrode arrays of the same design, implanted for three months, was minimal [73] . Since the electrodes used in this study were recessed, the tissues adjacent to the electrodes may not have been in contact with the entire surface of the electrodes, particularly in the acute setting. However, as there was minimal difference between chronic and acute Q inj , the recess is likely to have had a minimal effect on Q inj . There were minor variations in the acute and chronic tissue resistances as illustrated by the difference in the access voltage of the acute and chronic voltage transient [see Fig. 3 ]. Slight intersubject variations are inherent in in vivo studies, which may account for the differences in tissue resistance. However, the access voltage is not included in the calculation of E mc and, thus, does not contribute to Q inj [21] .
The access voltage is typically calculated from the voltage step of the voltage excursion waveform at the beginning or end of cathodic or anodic phases. However, the voltage step of the waveform at the beginning of the cathodic phase is larger than at the end, as demonstrated in [see Fig. 3 ]. This was likely a result of parasitic capacitance in the outputs of the stimulator, which is typical of constant-current stimulators. In between stimulation pulses, the parasitic capacitance in the stimulator is charged up to supply voltage. At the stimulus onset, the entire supply voltage is applied to the active electrode, which results in a voltage step which is greater than the access voltage alone [74] . E mc was measured during the interphase gap and, thus, calculation of the access voltage was not required to determine Q inj .
The cathodic and anodic phases of the voltage waveforms are slightly asymmetric [see Fig. 3 ]. The series capacitor accumulates charge during the cathodic phase and discharges during the anodic phase. If the potential delivered by the capacitor during the anodic phase is greater than the sum of that required to overcome the access resistance and deliver the desired current, the anodic and cathodic phases will be asymmetric. This is especially evident at the beginning of the anodic phase, where there is a voltage step that is greater than the expected access voltage. At the anodic phase offset, the working and counter electrodes are shorted allowing the capacitor to discharge and causing the potential to return to the interpulse potential with a larger step than would be expected from the access voltage alone. The anodic phase waveform is not used to calculate E mc and, thus, Q inj was not affected by the asymmetry.
The Q inj in the suprachoroidal space was not different to the Q inj using intracochlear electrodes, but was greater than that found on the cortical surface and this is likely due to differences in the anatomy and physiology of each location. The intracochlear electrode is implanted into the scala tympani, which is a fluid filled cavity where there may be less obstruction of diffusing electrolytes and the degree of fibrosis is highly variable. Suprachoroidal electrodes face the choroid which is well perfused and ensures a ready supply of electrolytes, although the blood vessel walls may hinder its availability to the electrode surface. This highlights the importance of understanding the effect of the implant location on Q inj and the need for in vivo testing in a location which is similar to the intended application.
Q inj can be measured with methods other than voltage transients [33] , [36] and this may produce different outcomes. For example, the method for measuring Q inj used by Brummer and Turner [36] , [41] examined the voltage excursion waveform shape. An asymptote in the waveform during the cathodic or anodic phase was used to indicate the evolution of hydrogen or oxygen, respectively. This asymptotic behaviour is not evident at the end of the cathodic phase in vivo and the slope remains steep [see Fig. 3 ]. Thus, Q inj in vivo determined using the method by Brummer and Turner may be higher than that found in the present study. However, since the animals used in this study were also part of separate studies where retinal and cochlear pathology were important outcomes, determination of Q inj with this method was not investigated.
Although we found that Q inj was very small in vivo, histopathological examination of cochleae which were chronically stimulated with charge densities of up to 52 μC/cm 2 with pulsewidths up to 200 μs showed no correlation between charge density and damage to surrounding structures [75] [76] [77] [78] . Similarly, acute cortical stimulation with a charge density of 40 μC/cm 2 and a pulsewidth of 100 μs resulted in only mild neural damage [9] . These charge densities are far greater than those defined as Q inj in vivo in this study. Therefore, although Q inj is sometimes used to define safe in vivo stimulation limits [79] , [80] , the clinical relevance of this measure, at least determined using voltage transients, is questionable.
The polarization of electrodes beyond the water window causes water electrolysis but tissue damage may not ensue. The evolution of oxygen and hydrogen gas can physically damage tissues if gas bubbles are formed. However, if the rate of gas production is not excessive, physical gassing may not occur since the gasses can dissolve into the tissue [81] , [82] . Electrolysis of water produces OH − and H + , and this may result in pH changes. However, physiological pH buffers may minimize pH shifts and, if both water oxidation and reduction occur, some H + ions may be neutralized by OH-ions [81] . By using charge balanced stimulation with capacitive coupling and electrode shorting, net pH changes can be minimized [22] . It should be noted that the pH close to the electrodes may change during the stimulation pulse and this may cause tissue damage [66] .
In the present study, we have adapted the predominantly in vitro technique of using potential transients to measure Q inj to the in vivo situation. Factors such as the permittivity of the tissue and positioning of the reference electrode may affect the measured Q inj in vivo. Thus, the measured Q inj in vivo may be less accurate compared with in vitro measurements. Further investigation into the accuracy of measuring Q inj in vivo may be necessary. Nonetheless, this method of determining Q inj is standard practice for evaluating biomedical electrodes in vivo [32] , [60] . An alternative to measuring Q inj would be to perform CV or electrochemical impedance spectroscopy. In order to determine practical guidelines on safe in vivo stimulation limits, chronic stimulation in a suitable animal model will be the most informative approach.
Measuring Q inj in vitro in a three-electrode model is a useful tool for comparing different materials, geometries, or stimulation protocols. However, the composition of the electrolyte [30] and differences in experimental setup can have significant effects on the findings. Thus, when comparing Q inj in vitro, the experimental setup should be comparable. It may also be advantageous to use capacitive coupling [22] and shorting between electrodes [59] to minimize residual direct current which could otherwise lead to variations in Q inj depending on the equipment and protocols used. It is also important to remember that findings using in vitro models may differ in vivo [21] .
In summary, the in vitro Q inj of Pt macroelectrodes varied from 34 to 54 μC/cm 2 for pulsewidths of 100 to 3200 μs, increasing with pulsewidth. Q inj was reduced to 11.5% to 30.8% of the in vitro levels when electrodes were placed in the suprachoroidal space acutely or chronically. There were significant differences in Q inj when electrodes were placed on the cortical surface but not the cochlea. The in vivo Q inj determined using voltage transients was found to significantly underestimate the safe stimulation limits determined using histopathological analysis found in the literature, possibly, because tissues can tolerate a degree of water electrolysis. This suggests that an alternative method for determining safe stimulation limits in vivo is required. Ultimately, chronic stimulation and histological examination using the electrode array and stimulation site for which the device is intended for is always required for the most rigorous measure of safe charge injection limits. 
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